Evidence map›Paper›PMID 36572418›Full record

ArticleEpidemiology and infection2022

Risk factors for

Saskia Schmitz, Christina Princk, Kristin Meyer-Schlinkmann, Maren Mylius, Nadja S Bier, Armin Baillot, Masyar Monazahian, Rainer G Ulrich, Anne Mayer-Scholl, Johannes Dreesman

Abstract read
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. A severe case of sepsis and pneumonia caused byOne health (Amsterdam, Netherlands) · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saskia SchmitzPublic Health Agency of Lower Saxony, Hanover, Germany.ORCID 0000-0002-8985-0655
Christina PrinckPublic Health Agency of Lower Saxony, Hanover, Germany.
Kristin Meyer-SchlinkmannPublic Health Agency of Lower Saxony, Hanover, Germany.
Maren MyliusPublic Health Agency of Lower Saxony, Hanover, Germany.
Nadja S BierDepartment Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Armin BaillotPublic Health Agency of Lower Saxony, Hanover, Germany.
Masyar MonazahianPublic Health Agency of Lower Saxony, Hanover, Germany.
Rainer G UlrichInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.ORCID 0000-0002-5620-1528
Anne Mayer-SchollDepartment Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Johannes DreesmanPublic Health Agency of Lower Saxony, Hanover, Germany.ORCID 0000-0002-3382-495X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated seroprevalence and factors associated with

Indexed as

LeptospiraLeptospirosisAntibodies, BacterialGermanyHumansImmunoglobulin GRisk FactorsSeroepidemiologic StudiesAntibodies, BacterialImmunoglobulin GLeptospira spprisk factorsrodent-borne diseasesseroprevalence

Identifiers

PMID36572418
PMCPMC9990393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.